AI Article Synopsis

  • Cryptococcoid Sweet syndrome (cSS) is a newly identified variant of Sweet syndrome (SS) that shares similar skin symptoms but shows unique microscopic features.
  • In cSS, fungal tests are negative, but biopsy results usually show positive myeloperoxidase (MPO) staining, indicating its distinct nature.
  • The rarity and complexities in diagnosing cSS often lead to poor health outcomes, yet this study presents a case where a patient had a positive recovery.

Article Abstract

Cryptococcoid Sweet syndrome (cSS) is a recently described clinical and histological variant of Sweet syndrome (SS). Its cutaneous presentation is similar to the classical form of SS but it includes atypical findings, such as capsular and yeast-like structures on microscopy that are reminiscent of species. However, in cSS, fungal staining and cultural examination are negative, whereas myeloperoxidase (MPO) staining on biopsy specimens is typically positive. Due to the rarity and the diagnostic challenge represented by this disease, its extracutaneous involvement, and the latency in its diagnosis, this condition is frequently associated with poor prognosis. In this study, we report the case of a cSS patient with a positive outcome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496249PMC
http://dx.doi.org/10.3389/fmed.2024.1468712DOI Listing

Publication Analysis

Top Keywords

sweet syndrome
12
cryptococcoid sweet
8
syndrome case
4
case report
4
report cryptococcoid
4
syndrome css
4
css described
4
described clinical
4
clinical histological
4
histological variant
4

Similar Publications

A Novel, Nonaquatic Zoonotic Transmission of .

Case Rep Infect Dis

December 2024

Department of Dermatology, North Bristol NHS Trust, Bristol, UK.

was first described in humans in 1954, known to infect fish species and contaminate water and fish products. Inoculation to humans occurs through injured skin resulting in the formation of a solitary nodule known as "fish tank granuloma." Disseminated infections have been reported in the immunocompromised and can present with extracutaneous manifestations such as arthritis and osteomyelitis.

View Article and Find Full Text PDF

Food-derived components with physiological effects have been attracting attention in recent years, and studies have comprehensively analyzed these components. In this study, we sought to identify food components with functional properties for the prevention and improvement of metabolic syndrome. We performed a luciferase reporter assay using fatty acid synthase (FAS) and low-density lipoprotein receptor (LDL) receptor gene promoters.

View Article and Find Full Text PDF

Orbital apex syndrome secondary to Sweet syndrome.

BMJ Case Rep

January 2025

Department of Ophthalmology, Rochdale Infirmary, Rochdale, UK.

Sweet syndrome (SS), or acute febrile neutrophilic dermatosis, is a dermatologic, auto-inflammatory disorder of unclear origin, often accompanied by systemic inflammation affecting various tissues, including the eyes. Common ocular manifestations include conjunctivitis but can extend to other ocular tissues. Orbital apex syndrome (OAS) involves damage to several cranial nerves transversing the orbital apex, leading to ophthalmoplegia and vision loss.

View Article and Find Full Text PDF

Objective: The effectiveness and optimal stimulation site of deep brain stimulation (DBS) for central poststroke pain (CPSP) remain elusive. The objective of this retrospective international multicenter study was to assess clinical as well as neuroimaging-based predictors of long-term outcomes after DBS for CPSP.

Methods: The authors analyzed patient-based clinical and neuroimaging data of previously published and unpublished cohorts from 6 international DBS centers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!